{
  "id": "3dfbe4f15efa4398",
  "title": "Lilly , chasing Novo , expects second - quarter FDA decision on obesity pill",
  "description": "20260114T210000Z",
  "content": "",
  "source": "biopharmadive.com",
  "source_url": "https://www.biopharmadive.com/news/lilly-obesity-pill-orforglipron-fda-decision-dtc-sales/809598/",
  "published_at": "20260114T210000Z",
  "fetched_at": "2026-01-15T00:21:56.842948+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.biopharmadive.com/news/lilly-obesity-pill-orforglipron-fda-decision-dtc-sales/809598/",
    "url_mobile": "",
    "title": "Lilly , chasing Novo , expects second - quarter FDA decision on obesity pill",
    "seendate": "20260114T210000Z",
    "socialimage": "https://imgproxy.divecdn.com/K3Vr8IzUBTVreZIXDG9hTVrfYMkKn9juhKMqkyzOwM0/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMjQ1MzYyOTkyXzEuanBn.webp",
    "domain": "biopharmadive.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}